Atlas Trials

Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration

Clinical trial NCT04700423 · COMPLETED

Trial details

NCT number
NCT04700423
Sponsor
Jennifer Keiser
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
TrichuriasisAscariasisHookworm InfectionsHelminthes; Infestation, Intestinal
Start date
2021-03-01
Primary completion
2021-08-18
Enrollment
536

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.